Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant fusion protein of circulary-permuted IL-4 and pseudomonas exotoxin A, [IL-4(38-37)-PE38KDEL]

EU orphan designation number: EU/3/08/553   
Active ingredient: Recombinant fusion protein of circulary-permuted IL-4 and pseudomonas exotoxin A, [IL-4(38-37)-PE38KDEL]
Indication: Treatment of glioma
Sponsor: Pharma Gateway AB
Johanneslundsvägen 2, 194 61 Upplands Väsby, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/06/2008 Orphan designation EMEA/OD/004/08 (2008)2540 of 03/06/2008
22/12/2015 Change of name and/or address of sponsor
11/01/2018 Change of name and/or address of sponsor
05/02/2018 Transfer of orphan designation EMA/OD/004/08/T/01 (2018)699 of 01/02/2018